{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:35:44Z","timestamp":1784309744142,"version":"3.55.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The global resurgence of pertussis in countries with high vaccination coverage has been a concern of public health.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Nasopharyngeal swabs were collected for <jats:italic toggle=\"yes\">Bordetella pertussis<\/jats:italic> culture from children with suspected pertussis. Clinical and vaccination information were reviewed through electronic medical chart and immunization record. Antibiotics susceptibility was evaluated using E-test for erythromycin, azithromycin, clarithromycin and sulfamethoxazole\/trimethoprim. The MLST genotypes and 7 antigenic genes (<jats:italic toggle=\"yes\">ptxP<\/jats:italic>, <jats:italic toggle=\"yes\">ptxA, ptxC, Prn<\/jats:italic>, <jats:italic toggle=\"yes\">fim3, fim2 and tcfA<\/jats:italic>) of <jats:italic toggle=\"yes\">Bordetella pertussis<\/jats:italic> were identified by polymerase chain reaction amplification and sequencing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During January 2016 to September 2017, a total of 141 children 1\u201348 months of age were culture-confirmed with pertussis, of whom 98 (69.5%) were younger than 6 months, 25 (17.7%) had completed at least 3 doses of DTaP and 75 (53.2%) had a clear exposure to household members with persistent cough. Fully vaccinated cases manifested milder disease than unvaccinated and not-fully vaccinated cases. All strains were MLST2. High-virulent strains characteristic of <jats:italic toggle=\"yes\">ptxP3<\/jats:italic>\/<jats:italic toggle=\"yes\">prn2<\/jats:italic>\/<jats:italic toggle=\"yes\">ptxC2<\/jats:italic> constituted 41.1% (58\/141) and were all susceptible to macrolides while low-virulent strains characteristic of <jats:italic toggle=\"yes\">ptxP1<\/jats:italic>\/<jats:italic toggle=\"yes\">prn1<\/jats:italic>\/<jats:italic toggle=\"yes\">ptxC1<\/jats:italic> constituted 58.9% (83\/141) and 97.6% (81\/83), respectively, were highly resistant to macrolides.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Pertussis is resurging among infants and young children in Shanghai, and household transmission is the main exposure pathway. The high-virulent strains harboring ptxP3\/prn2\/ptxC2 and the macrolide-resistant <jats:italic toggle=\"yes\">Bordetella pertussis<\/jats:italic> strains are quite prevalent. These issues impose a public health concern in Shanghai. Our findings are important to modify the DTaP vaccination strategy and the management guideline of pertussis in China.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002160","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:52:35Z","timestamp":1535586755000},"page":"370-376","source":"Crossref","is-referenced-by-count":54,"title":["Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016\u20132017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance"],"prefix":"10.1097","volume":"38","author":[{"given":"Pan","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology Laboratory, Clinical Laboratory Medicine, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology Laboratory, Clinical Laboratory Medicine, Children\u2019s Hospital of Fudan University, Shanghai, China"},{"name":"Department of Nosocomial Infection Control, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrmicro3235","article-title":"Bordetella pertussis pathogenesis: current and future challenges.","volume":"12","author":"Melvin","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/GRF.0b013e31824f3b38","article-title":"Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants.","volume":"55","author":"Gall","year":"2012","journal-title":"Clin Obstet Gynecol"},{"issue":"RR-4","key":"R3-20230912","first-page":"1","article-title":"Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"57","author":"Murphy","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00430-017-0524-z","article-title":"Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.","volume":"207","author":"Dorji","year":"2018","journal-title":"Med Microbiol Immunol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960050435","article-title":"Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.","volume":"19","author":"Kerr","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/hv.26335","article-title":"Seroprevalence of pertussis in China: need to improve vaccination strategies.","volume":"10","author":"Xu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JCM.40.6.1994-2001.2002","article-title":"Multilocus sequence typing of Bordetella pertussis based on surface protein genes.","volume":"40","author":"van Loo","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"e18190","DOI":"10.5812\/jjm.8(5)2015.18190","article-title":"Isolation of high level macrolide resistant Bordetella pertussis without transition mutation at domain V in Iran.","volume":"8","author":"Mirzaei","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-016-2655-3","article-title":"Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012\u20132013[J].","volume":"35","author":"Du","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1099\/jmm.0.000688","article-title":"Molecular epidemiology of Bordetella pertussis in Greece, 2010\u20132015[J].","volume":"67","author":"Petridou","year":"2018","journal-title":"J Med Microbiol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","article-title":"Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.","volume":"15","author":"Mooi","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jinf.2015.11.004","article-title":"The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis.","volume":"72","author":"Clarke","year":"2016","journal-title":"J Infect"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3201\/eid1805.110812","article-title":"Temporal trends in Bordetella pertussis populations, Denmark, 1949\u20132010[J].","volume":"18","author":"Petersen","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/INF.0000000000001814","article-title":"Pertussis outbreak in a primary school in China: infection and transmission of the macrolide-resistant Bordetella pertussis[J].","volume":"37","author":"Liu","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R15-20230912","first-page":"e138941","article-title":"Variation in Bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970\u20132014)[J].","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"R16-20230912","first-page":"1358","article-title":"[The status of pertussis infection and molecular epidemiological characteristics of pertussis in Tianjin, 2013][J].","volume":"35","author":"Liu","year":"2014","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"RR-14","key":"R17-20230912","first-page":"1","article-title":"Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines.","volume":"54","author":"Tiwari","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"R18-20230912","first-page":"590","article-title":"Principles and practice of pediatric infectious diseases[M].","volume":"89","author":"Sarah","year":"2004","journal-title":"Arch Dis Child"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s100960050455","article-title":"Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.","volume":"19","author":"Mooi","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1128\/JCM.42.11.5364-5367.2004","article-title":"Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.","volume":"42","author":"Tsang","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JCM.40.6.1994-2001.2002","article-title":"Multilocus sequence typing of Bordetella pertussis based on surface protein genes.","volume":"40","author":"van Loo","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"Pt 5","key":"R22-20230912","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1099\/jmm.0.05515-0","article-title":"Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.","volume":"53","author":"Packard","year":"2004","journal-title":"J Med Microbiol"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0000000000001366","article-title":"Antimicrobial susceptibility and molecular detection of Pertactin-producing and Pertactin-deficient Bordetella pertussis.","volume":"36","author":"Souder","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20230912","first-page":"22","article-title":"Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria","volume":"M45","year":"2013"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"e1315","DOI":"10.1128\/genomeA.01394-15","article-title":"Complete genome sequences of 11 Bordetella pertussis strains representing the pandemic ptxP3 lineage[J].","volume":"3","author":"Bart","year":"2015","journal-title":"Genome Announc"},{"key":"R26-20230912","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - September 2015[J].","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"O825","DOI":"10.1111\/1469-0691.12671","article-title":"High prevalence of erythromycin-resistant Bordetella pertussis in Xi\u2019an, China.","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1016\/j.vaccine.2015.10.133","article-title":"A sera-epidemiological study on pertussis immunity levels among community populations and an analysis of the underlying factors in Tianjin China.","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"R29-20230912","first-page":"e155965","article-title":"Is pertussis infection neglected in China? Evidence from a seroepidemiology survey in Zhejiang, an Eastern Province of China[J].","volume":"11","author":"He","year":"2016","journal-title":"PLoS One"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.puhe.2017.12.009","article-title":"Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection.","volume":"156","author":"Yao","year":"2018","journal-title":"Public Health"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.vaccine.2010.12.103","article-title":"Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China.","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40272-015-0149-x","article-title":"Protecting newborns against pertussis: treatment and prevention strategies.","volume":"17","author":"Salim","year":"2015","journal-title":"Paediatr Drugs"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"a029629","DOI":"10.1101\/cshperspect.a029629","article-title":"What is wrong with pertussis vaccine immunity? Inducing and recalling vaccine-specific immunity[J].","volume":"9","author":"Eberhardt","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1080\/21645515.2015.1062954","article-title":"Seroepidemiology of diphtheria and pertussis in Beijing, China: a cross-sectional study.","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10096-014-2216-6","article-title":"Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959\u20132013[J].","volume":"34","author":"Mosiej","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"e77165","DOI":"10.1371\/journal.pone.0077165","article-title":"Genetic analysis of Bordetella pertussis isolates from the 2008\u20132010 pertussis epidemic in Japan[J].","volume":"8","author":"Miyaji","year":"2013","journal-title":"PLoS One"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006454-199505000-00010","article-title":"Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.","volume":"14","author":"Lewis","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","article-title":"Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.","volume":"10","author":"Mooi","year":"2010","journal-title":"Infect Genet Evol"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/644733","article-title":"Bordetella pertussis and pertussis vaccines.","volume":"49","author":"Guiso","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:35:41Z","timestamp":1694558141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002160","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}